≡ Risteys
R10

Documentation Changelog GitHub Contact & Feedback

Lymphoid leukaemia (controls excluding all cancers)

Endpoint Browser PheWeb

CD2_LYMPHOID_LEUKAEMIA_EXALLC

No definition available.

Endpoint definition

↥
FinnGen phenotype data

individuals

diagram downward connector

Apply sex-specific rule None

diagram downward connector

Check conditions None

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 C91
Hospital discharge: ICD-9 204
Hospital discharge: ICD-8 204
Cause of death: ICD-10 C91
Cause of death: ICD-9 204
Cause of death: ICD-8 204

2 out of 7 registries used, show all original rules.

-

diagram downward connector

Check minimum number of events None

-

diagram downward connector

Include endpoints None

-

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

1617

diagram downward connector
CD2_LYMPHOID_LEUKAEMIA_EXALLC

Control definitions

Control exclude C3_CANCER

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF4
Parent code in ICD-10 C81-C96
Name in latin Leuc(h)aemia lymphatica

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 1617 622 995
Unadjusted prevalence (%) 0.39 0.27 0.55
Mean age at first event (years) 58.58 54.13 61.37

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.09 4.93 [2.97, 8.19] 7.5e-10 431
15 years 0.02 2.27 [1.31, 3.94] 3.5e-3 176
5 years 0.01 4.30 [3.04, 6.10] 2.5e-16 134
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: CD2_LYMPHOID_LEUKAEMIA_EXALLC – Lymphoid leukaemia (controls excluding all cancers)
GWS hits: 7

Survival analyses between endpoints

↥

Plot

before Lymphoid leukaemia (controls excluding all cancers)
after Lymphoid leukaemia (controls excluding all cancers)

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Lymphoid leukaemia (controls excluding all cancers)

↥

Endpoint not on priority list, no data to show.